- Report
- December 2023
- 147 Pages
Global
From €2218EUR$2,475USD£1,934GBP
€4436EUR$4,950USD£3,867GBP
- Report
- November 2024
- 160 Pages
Global
From €5332EUR$5,950USD£4,649GBP
- Report
- October 2024
- 120 Pages
United States
From €5332EUR$5,950USD£4,649GBP
- Report
- March 2025
- 142 Pages
Global
From €3584EUR$3,999USD£3,124GBP
- Report
- February 2025
- 140 Pages
Global
From €3584EUR$3,999USD£3,124GBP
- Report
- August 2025
- 200 Pages
Saudi Arabia
From €2232EUR$2,490USD£1,945GBP
- Report
- July 2025
- 200 Pages
Saudi Arabia
From €2232EUR$2,490USD£1,945GBP
- Report
- June 2025
- 200 Pages
Australia
From €2232EUR$2,490USD£1,945GBP
- Report
- June 2024
- 210 Pages
Global
From €2052EUR$2,290USD£1,789GBP
- Report
- August 2023
- 370 Pages
Global
From €2232EUR$2,490USD£1,945GBP
- Report
- July 2023
- 210 Pages
Global
From €1783EUR$1,990USD£1,555GBP
- Report
- January 2023
- 170 Pages
China
From €2232EUR$2,490USD£1,945GBP
- Report
- November 2022
- 125 Pages
Global
From €2232EUR$2,490USD£1,945GBP
- Report
- July 2025
- 200 Pages
Mexico
From €2232EUR$2,490USD£1,945GBP
- Report
- August 2024
Global
From €4436EUR$4,950USD£3,867GBP
- Report
- July 2024
Global
From €4436EUR$4,950USD£3,867GBP
- Report
- June 2024
Global
From €4436EUR$4,950USD£3,867GBP
- Report
- September 2023
- 76 Pages
Global
From €4436EUR$4,950USD£3,867GBP
- Report
- June 2023
- 69 Pages
Global
From €4436EUR$4,950USD£3,867GBP
- Report
- June 2023
- 65 Pages
Global
From €4436EUR$4,950USD£3,867GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more